Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
Masatoshi Kudo
Abstract
N/A
Topics & Concepts
AtezolizumabBevacizumabMedicineHepatocellular carcinomaStage (stratigraphy)OncologyInternal medicineCancerChemotherapyImmunotherapyPembrolizumabBiologyPaleontologyHepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and StudiesCancer, Hypoxia, and Metabolism